Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Validation of a clinical-genetics score to predict hemorrhagic transformations after rtPA.

Carrera C, Cullell N, Torres-Águila N, Muiño E, Bustamante A, Dávalos A, López-Cancio E, Ribó M, Molina CA, Giralt-Steinhauer E, Soriano-Tárraga C, Mola-Caminal M, Jiménez-Conde J, Roquer J, Vives-Bauza C, Navarro RD, Obach V, Arenillas JF, Segura T, Serrano-Heras G, Martí-Fàbregas J, Freijo M, Cabezas JA, Tatlisumak T, Heitsch L, Ibañez L, Cruchaga C, Lee JM, Strbian D, Montaner J, Fernández-Cadenas I; Spanish Stroke Genetic Consortium.

Neurology. 2019 Aug 27;93(9):e851-e863. doi: 10.1212/WNL.0000000000007997. Epub 2019 Jul 31.

PMID:
31366724
2.

PATJ Low Frequency Variants Are Associated With Worse Ischemic Stroke Functional Outcome.

Mola-Caminal M, Carrera C, Soriano-Tárraga C, Giralt-Steinhauer E, Díaz-Navarro RM, Tur S, Jiménez C, Medina-Dols A, Cullell N, Torres-Aguila NP, Muiño E, Rodríguez-Campello A, Ois A, Cuadrado-Godia E, Vivanco-Hidalgo RM, Hernandez-Guillamon M, Solé M, Delgado P, Bustamante A, García-Berrocoso T, Mendióroz M, Castellanos M, Serena J, Martí-Fàbregas J, Segura T, Serrano-Heras G, Obach V, Ribó M, Molina CA, Alvarez-Sabín J, Palomeras E, Freijo M, Font MA, Rosand J, Rost NS, Gallego-Fabrega C, Lee JM, Heitsch L, Ibanez L, Cruchaga C, Phuah CL, Lemmens R, Thijs V, Lindgren A, Maguire J, Rannikmae K, Sudlow CL, Jern C, Stanne TM, Lorentzen E, Muñoz-Narbona L, Dávalos A, López-Cancio E, Worrall BB, Woo D, Kittner SJ, Mitchell BD, Montaner J, Roquer J, Krupinski J, Estivill X, Rabionet R, Vives-Bauzá C, Fernández-Cadenas I, Jiménez-Conde J.

Circ Res. 2019 Jan 4;124(1):114-120. doi: 10.1161/CIRCRESAHA.118.313533.

PMID:
30582445
3.

Role of retinal pigment epithelium-derived exosomes and autophagy in new blood vessel formation.

Atienzar-Aroca S, Serrano-Heras G, Freire Valls A, Ruiz de Almodovar C, Muriach M, Barcia JM, Garcia-Verdugo JM, Romero FJ, Sancho-Pelluz J.

J Cell Mol Med. 2018 Nov;22(11):5244-5256. doi: 10.1111/jcmm.13730. Epub 2018 Aug 21.

4.

The UCP2-866G/A Polymorphism Could be Considered as a Genetic Marker of Different Functional Prognosis in Ischemic Stroke After Recanalization.

Díaz-Maroto Cicuéndez I, Fernández-Díaz E, García-García J, Jordán J, Fernández-Cadenas I, Montaner J, Serrano-Heras G, Segura T.

Neuromolecular Med. 2017 Dec;19(4):571-578. doi: 10.1007/s12017-017-8470-x. Epub 2017 Oct 17.

PMID:
29043564
5.

Histopathological and Bacteriological Analysis of Thrombus Material Extracted During Mechanical Thrombectomy in Acute Stroke Patients.

Hernández-Fernández F, Rojas-Bartolomé L, García-García J, Ayo-Martín Ó, Molina-Nuevo JD, Barbella-Aponte RA, Serrano-Heras G, Juliá-Molla E, Pedrosa-Jiménez MJ, Segura T.

Cardiovasc Intervent Radiol. 2017 Dec;40(12):1851-1860. doi: 10.1007/s00270-017-1718-x. Epub 2017 Jun 6.

PMID:
28589250
6.

Targeting basal-like breast tumors with bromodomain and extraterminal domain (BET) and polo-like kinase inhibitors.

Nieto-Jiménez C, Alcaraz-Sanabria A, Pérez-Peña J, Corrales-Sánchez V, Serrano-Heras G, Galán-Moya EM, Serrano-Oviedo L, Montero JC, Burgos M, Llopis J, Pandiella A, Ocaña A.

Oncotarget. 2017 Mar 21;8(12):19478-19490. doi: 10.18632/oncotarget.14465.

7.

PPM1A Methylation Is Associated With Vascular Recurrence in Aspirin-Treated Patients.

Gallego-Fabrega C, Carrera C, Reny JL, Fontana P, Slowik A, Pera J, Pezzini A, Serrano-Heras G, Segura T, Bin Dukhyil AA, Martí-Fàbregas J, Muiño E, Cullell N, Montaner J, Krupinski J, Fernandez-Cadenas I.

Stroke. 2016 Jul;47(7):1926-9. doi: 10.1161/STROKEAHA.116.013340. Epub 2016 Jun 14.

PMID:
27301936
8.

In Silico Analysis Guides Selection of BET Inhibitors for Triple-Negative Breast Cancer Treatment.

Pérez-Peña J, Serrano-Heras G, Montero JC, Corrales-Sánchez V, Pandiella A, Ocaña A.

Mol Cancer Ther. 2016 Aug;15(8):1823-33. doi: 10.1158/1535-7163.MCT-16-0004. Epub 2016 Jun 2.

9.

TRAF3 Epigenetic Regulation Is Associated With Vascular Recurrence in Patients With Ischemic Stroke.

Gallego-Fabrega C, Carrera C, Reny JL, Fontana P, Slowik A, Pera J, Pezzini A, Serrano-Heras G, Segura T, Martí-Fàbregas J, Muiño E, Cullell N, Montaner J, Krupinski J, Fernandez-Cadenas I.

Stroke. 2016 May;47(5):1180-6. doi: 10.1161/STROKEAHA.115.012237. Epub 2016 Mar 29.

PMID:
27026631
10.

Oxidative stress in retinal pigment epithelium cells increases exosome secretion and promotes angiogenesis in endothelial cells.

Atienzar-Aroca S, Flores-Bellver M, Serrano-Heras G, Martinez-Gil N, Barcia JM, Aparicio S, Perez-Cremades D, Garcia-Verdugo JM, Diaz-Llopis M, Romero FJ, Sancho-Pelluz J.

J Cell Mol Med. 2016 Aug;20(8):1457-66. doi: 10.1111/jcmm.12834. Epub 2016 Mar 21.

11.

Circulating DNA and Survival in Solid Tumors.

Ocaña A, Díez-González L, García-Olmo DC, Templeton AJ, Vera-Badillo F, José Escribano M, Serrano-Heras G, Corrales-Sánchez V, Seruga B, Andrés-Pretel F, Pandiella A, Amir E.

Cancer Epidemiol Biomarkers Prev. 2016 Feb;25(2):399-406. doi: 10.1158/1055-9965.EPI-15-0893. Epub 2015 Nov 24. Review.

12.

Phospho-kinase profile of colorectal tumors guides in the selection of multi-kinase inhibitors.

Serrano-Heras G, Cuenca-López MD, Montero JC, Corrales-Sanchez V, Morales JC, Núñez LE, Morís F, Pandiella A, Ocaña A.

Oncotarget. 2015 Oct 13;6(31):31272-83. doi: 10.18632/oncotarget.5211.

13.

Propranolol reduces viability and induces apoptosis in hemangioblastoma cells from von Hippel-Lindau patients.

Albiñana V, Villar Gómez de Las Heras K, Serrano-Heras G, Segura T, Perona-Moratalla AB, Mota-Pérez M, de Campos JM, Botella LM.

Orphanet J Rare Dis. 2015 Sep 22;10:118. doi: 10.1186/s13023-015-0343-5.

14.

Antitumor activity of the novel multi-kinase inhibitor EC-70124 in triple negative breast cancer.

Cuenca-López MD, Serrano-Heras G, Montero JC, Corrales-Sánchez V, Gomez-Juarez M, Gascón-Escribano MJ, Morales JC, Voisin V, Núñez LE, Morís F, Bader GD, Pandiella A, Ocaña A.

Oncotarget. 2015 Sep 29;6(29):27923-37. doi: 10.18632/oncotarget.4736.

15.

Real-time PCR detection chemistry.

Navarro E, Serrano-Heras G, Castaño MJ, Solera J.

Clin Chim Acta. 2015 Jan 15;439:231-50. doi: 10.1016/j.cca.2014.10.017. Epub 2014 Oct 22. Review.

PMID:
25451956
16.

Crystal structure and functional insights into uracil-DNA glycosylase inhibition by phage Φ29 DNA mimic protein p56.

Baños-Sanz JI, Mojardín L, Sanz-Aparicio J, Lázaro JM, Villar L, Serrano-Heras G, González B, Salas M.

Nucleic Acids Res. 2013 Jul;41(13):6761-73. doi: 10.1093/nar/gkt395. Epub 2013 May 13.

17.

Role of host factors in bacteriophage φ29 DNA replication.

Muñoz-Espín D, Serrano-Heras G, Salas M.

Adv Virus Res. 2012;82:351-83. doi: 10.1016/B978-0-12-394621-8.00020-0. Review.

PMID:
22420858
18.

NIH-3T3 fibroblasts cultured with plasma from colorectal cancer patients generate poorly differentiated carcinomas in mice.

Serrano-Heras G, Domínguez-Berzosa C, Collantes E, Guadalajara H, García-Olmo D, García-Olmo DC.

Cancer Lett. 2012 Mar;316(1):85-90. doi: 10.1016/j.canlet.2011.10.028. Epub 2011 Oct 25.

PMID:
22093615
19.

Novel dimeric structure of phage φ29-encoded protein p56: insights into uracil-DNA glycosylase inhibition.

Asensio JL, Pérez-Lago L, Lázaro JM, González C, Serrano-Heras G, Salas M.

Nucleic Acids Res. 2011 Dec;39(22):9779-88. doi: 10.1093/nar/gkr667. Epub 2011 Sep 2.

20.

Characterization of Bacillus subtilis uracil-DNA glycosylase and its inhibition by phage φ29 protein p56.

Pérez-Lago L, Serrano-Heras G, Baños B, Lázaro JM, Alcorlo M, Villar L, Salas M.

Mol Microbiol. 2011 Jun;80(6):1657-66. doi: 10.1111/j.1365-2958.2011.07675.x. Epub 2011 May 12.

21.

Phage phi29 protein p56 prevents viral DNA replication impairment caused by uracil excision activity of uracil-DNA glycosylase.

Serrano-Heras G, Bravo A, Salas M.

Proc Natl Acad Sci U S A. 2008 Dec 9;105(49):19044-9. doi: 10.1073/pnas.0808797105. Epub 2008 Oct 9.

22.

Protein p56 from the Bacillus subtilis phage phi29 inhibits DNA-binding ability of uracil-DNA glycosylase.

Serrano-Heras G, Ruiz-Masó JA, del Solar G, Espinosa M, Bravo A, Salas M.

Nucleic Acids Res. 2007;35(16):5393-401. Epub 2007 Aug 13.

23.

A uracil-DNA glycosylase inhibitor encoded by a non-uracil containing viral DNA.

Serrano-Heras G, Salas M, Bravo A.

J Biol Chem. 2006 Mar 17;281(11):7068-74. Epub 2006 Jan 18.

24.

A new plasmid vector for regulated gene expression in Bacillus subtilis.

Serrano-Heras G, Salas M, Bravo A.

Plasmid. 2005 Nov;54(3):278-82. Epub 2005 Jun 6.

PMID:
15941587
25.

Compartmentalization of prokaryotic DNA replication.

Bravo A, Serrano-Heras G, Salas M.

FEMS Microbiol Rev. 2005 Jan;29(1):25-47. Review.

26.

In vivo assembly of phage phi 29 replication protein p1 into membrane-associated multimeric structures.

Serrano-Heras G, Salas M, Bravo A.

J Biol Chem. 2003 Oct 17;278(42):40771-7. Epub 2003 Aug 6.

27.

Supplemental Content

Loading ...
Support Center